We first investigated the microglial Dkk2 expression pattern in the APPNL-G-F knock-in AD mouse model, which develops robust pathology from the physiological expression of humanized mouse amyloid precursor protein (App) harboring Swedish, Beyreuther/Iberian, and Arctic mutations (Saito et al., 2014). This evidence concerns the gene APP and Alzheimer disease.